FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with ...
Fungal infections may not be as common as bacterial or viral infections, but they can still be deadly. And the deadliest pathogenic fungi, such as Candida auris, are becoming increasingly resistant to ...